相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models
Odelaisy Leon-Triana et al.
COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION (2021)
CAR T cells for T-cell leukemias: Insights from mathematical models
Victor M. Perez-Garcia et al.
COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION (2021)
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
Mattia D'Agostino et al.
LEUKEMIA (2020)
Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
Stephen J. Bagley et al.
PHARMACOLOGY & THERAPEUTICS (2020)
PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
Eileen McGowan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
Prativa Sahoo et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2020)
Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies
Anni S. Halkola et al.
JOURNAL OF THEORETICAL BIOLOGY (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Mustafa Khasraw et al.
CLINICAL CANCER RESEARCH (2020)
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong et al.
CANCER CELL (2020)
Universal scaling laws rule explosive growth in human cancers
Victor M. Perez-Garcia et al.
NATURE PHYSICS (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
Elizabeth L. Siegler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Mathematical modeling of tumor-immune cell interactions
Grace E. Mahlbacher et al.
JOURNAL OF THEORETICAL BIOLOGY (2019)
Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade
Mohamed Amine Benchaib et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
Sara Ghorashian et al.
NATURE MEDICINE (2019)
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Xiao Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
Kerri-Ann Norton et al.
PROCESSES (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Toxicities of CD19 CAR-T cell immunotherapy
Alexandre V. Hirayama et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells
Andrew M. Stein et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
Julio C. Chavez et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma
Michael P. Brown et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Current Progress in CAR-T Cell Therapy for Solid Tumors
Shuo Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou N. Androulla et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Driving cars to the clinic for solid tumors
Mauro Castellarin et al.
GENE THERAPY (2018)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MATHEMATICAL MODEL OF CHIMERIC ANTI-GENE RECEPTOR (CAR) T CELL THERAPY WITH PRESENCE OF CYTOKINE
Reihaneh Mostolizadeh et al.
NUMERICAL ALGEBRA CONTROL AND OPTIMIZATION (2018)
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
Kai-chao Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling
Anna Konstorum et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients
J. Pan et al.
LEUKEMIA (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
Kristen M. Hege et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
From concept to clinic: Mathematically informed immunotherapy
Rachel Walker et al.
CURRENT PROBLEMS IN CANCER (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A stochastic model for immunotherapy of cancer
Martina Baar et al.
SCIENTIFIC REPORTS (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
Quan-shun Wang et al.
MOLECULAR THERAPY (2015)
Growth dynamics of untreated glioblastomas in vivo
Anne Line Stensjoen et al.
NEURO-ONCOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
The mathematics of cancer: integrating quantitative models
Philipp M. Altrock et al.
NATURE REVIEWS CANCER (2015)
Modeling cancer-immune responses to therapy
L. G. dePillis et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Meenakshi Hegde et al.
MOLECULAR THERAPY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models
Raluca Eftimie et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2011)
The role of B lymphocytes as antigen-presenting cells
Xinjian Chen et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
分享论文
